Pathogenesis of PR3-ANCA associated vasculitis

Journal of Autoimmunity

Volumn 30, Issue 1-2, 2008, Pages 29-36

  Kallenberg, C G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ANCA associated vasculitis; Pathogenesis; Proteinase 3 ANCA; Wegener's granulomatosis

Indexed keywords

MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

AUTOIMMUNITY; CELL DIFFERENTIATION; CELLULAR IMMUNITY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; VASCULITIS; WEGENER GRANULOMATOSIS;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHURG-STRAUSS SYNDROME; HUMANS; IMMUNITY, CELLULAR; MYELOBLASTIN; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEROXIDASE; STAPHYLOCOCCUS AUREUS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 38049051222     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.11.005     Document Type: Review

References (60)

1. Jennette J.C., and Falk R.J. Small vessel vasculitis. N Engl J Med 37 (1997) 1512-1523
2. Kallenberg C.G. Churg-Strauss syndrome: just one disease entity?. Arthritis Rheum 52 (2005) 2589-2593
3. Franssen C.F.M., Stegeman C.A., Kallenberg C.G.M., Gans R.O.B., de Jong P.E., Hoorntje S.J., et al. Antiproteinase 3 - and antimyeloperoxidase-associated vasculitis. Kidney Int 57 (2000) 2195-2206
4. Heeringa P., Huugen D., and Cohen Tervaert J.W. Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?. Trends Immunol 26 (2005) 561-564
5. Choi H.K., Liu S., Merkel P.A., Colditz G.A., and Niles J.L. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J Rheumatol 28 (2001) 1584-1590
6. Kallenberg C.G.M. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase. In: Shoenfeld Y., Gershwin M.E., and Meroni P.L. (Eds). Autoantibodies. 2nd ed. (2007), Elsevier, London 95-103
7. Xiao H., Heeringa P., Hu P., Liu Z., Zhao M., Aratani Y., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110 (2002) 955-963
8. Little M.A., Smyth C.L., Yadav R., Ambrose L., Cook H.T., Nourshargh S., et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interaction in vivo. Blood 106 (2005) 2050-2058
9. van der Woude F.J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L.A., et al. Autoantibodies to neutrophils and monocytes: a new tool for diagnosis and a marker of disease activity in Wegener's Granulomatosis. Lancet ii (1985) 425-429
10. Cohen Tervaert J.W., van der Woude F.J., Fauci A.S., Ambrus J.L., Velosa J., Keane W.F., et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149 (1989) 2461-2465
11. Cohen Tervaert J.W., Huitema M.G., Hené R.J., Sluiter W.J., The T.H., van der Hem G.K., et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336 (1990) 709-711
12. Kerr G.R., Fleischer T.A., Hallahan C.W., Leavitt R.Y., Fauci A.S., and Hoffman G.S. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 36 (1993) 365-371
13. Nowack R., Grab I., Flores-Suarez L.F., Schnulle P., Yard B., and van der Woude F.J. ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 16 (2001) 1631-1637
14. Boomsma M.M., Stegeman C.A., van der Leij M.J., Oost W., Hermans J., Kallenberg C.G.M., et al. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 43 (2000) 2025-2033
15. Sanders J.S., Huitema M.G., Kallenberg C.G., and Stegeman C.A. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. Rheumatology 45 (2006) 724-729
16. Keogh K.A., Ytterberg S.R., Fervenza F.C., Carlson K.A., Schroeder D.R., and Specks U. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 173 (2006) 180-187
17. Rarok A.A., Limburg P.C., and Kallenberg C.G. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol 74 (2003) 3-15
18. Halbwachs-Mecarelli L., Bessou G., Lesavre P., Lopez S., and Witko-Sarsat V. Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett 374 (1995) 29-33
19. Schreiber A., Busjahn A., Luft F.C., and Kettritz R. Membrane expression of proteinase 3 is genetically determined. J Am Soc Nephrol 14 (2003) 68-75
20. Witko-Sarsat V., Lesavre P., Lopez S., Bessou G., Hieblot C., Prum B., et al. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 10 (1999) 1224-1233
21. Rarok A.A., Stegeman C.A., Limburg P.C., and Kallenberg C.G.M. Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis. J Am Soc Nephrol 13 (2002) 2232-2238
22. van Rossum A.P., Rarok A.A., Huitema M.G., Fassina G., Limburg P.C., and Kallenberg C.G.M. Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies. J Leukoc Biol 76 (2004) 1162-1170
23. Pfister H., Ollert M., Fröhlich L.F., Quintanilla-Martinez L., Colby T.V., Specks U., et al. Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 104 (2004) 1411-1418
24. van der Geld Y.M., Hellmark T., Selga D., Heeringa P., Huitema M.G., Limburg P., et al. Rats and mice immunized with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes. Ann Rheum Dis 66 (July 20 2007) 1679-1682
25. Tomer Y., Gilburd B., Blank M., Lider O., Hershkoviz R., Fishman P., et al. Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum 38 (1995) 1375-1381
26. Popa E.R., Stegeman C.A., Bos N.A., Kallenberg C.G.M., and Cohen Tervaert J.W. Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol 103 (1999) 885-894
27. Lamprecht P. Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin Exp Immunol 141 (2005) 201-210
28. Abdulahad W.H., van der Geld Y.M., Stegeman C.A., and Kallenberg C.G.M. Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. Kidney Int 70 (2006) 938-947
29. Lamprecht P., Bruhl H., Erdmann A., Holl-Ulrich K., Csernok E., Seitzer U., et al. Differences in CCR5 expression on peripheral blood CD4+ CD28- T-cells and in granulomatous lesions between localized and generalized Wegener's granulomatosis. Clin Immunol 108 (2003) 1-7
30. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immun 8 (2007) 950-957
31. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
32. Abdulahad W.H., Stegeman C.A., van der Geld Y.M., Doornbos-van der Meer B., Limburg P.C., and Kallenberg C.G. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 56 (2007) 2080-2091
33. Stegeman C.A., Cohen Tervaert J.W., Sluiter W.J., Manson W.L., de Jong P.E., and Kallenberg C.G.M. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120 (1994) 12-17
34. Stegeman C.A., Cohen Tervaert J.W., de Jong P.E., and Kallenberg C.G.M. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 335 (1996) 16-20
35. Popa E.R., Stegeman C.A., Kallenberg C.G.M., and Cohen Tervaert J.W. Staphylococcus aureus and Wegener's granulomatosus. Arthritis Res 4 (2002) 77-79
36. Brons R.H., Bakker H.I., van Wijk R.T., van Dijk N.W., Muller Kobold A.C., Limburg P.C., et al. Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?. Clin Exp Immunol 119 (2000) 566-573
37. Heeringa P., Brouwer E., Klok P.A., Huitema M.G., van den Born J., Weening J.J., et al. Autoantibodies to Myeloperoxidase Aggravate Mild Anti-Glomerular-Basement-Membrane-Mediated Glomerular Injury in the Rat. Am J Pathol 149 (1996) 1695-1706
38. Pendergraft III W.F., Preston G.A., Shah R.R., Tropsha A., Carter Jr. C.W., Jennette J.C., et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nature Med 10 (2004) 72-79
39. Akaogi J., Barker T., Kuroda Y., Nacionales D.C., Yamasaki Y., Stevens B.R., et al. Role of non-protein amino acid L-canavanine in autoimmunity. Autoimmun Rev 5 (2006) 429-435
40. Alvarado-Sanchez B., Hernandez-Castro B., Portales-Perez D., Baranda L., Layseca-Espinosa E., Abud-Mendoza C., et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 27 (2006) 110-118
41. Eaton W.W., Rose N.R., Kalaydjian A., Pedersen M.G., and Mortensen P.B. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 29 (2007) 1-9
42. Furuzawa-Carballeda J., Vargas-Rojas M.I., and Cabral A.R. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6 (2007) 169-175
43. Gonnella P.A., Chen Y.H., Waldner H., and Weiner H.L. Induction of oral tolerization in CD86 deficient mice: a role for CD86 and B cells in the up-regulation of TGF-beta. J Autoimmun 26 (2006) 73-81
44. Konova E., Atanasova M., Stoykov S., Velkova A., and Shoenfeld Y. Idiotypic and anti-idiotypic elastin autoantibodies: implications for IVIg and pregnancy loss. J Autoimmun 28 (2007) 46-54
45. Lleo A., Invernizzi P., Selmi C., Coppel R.L., Alpini G., Podda M., et al. Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 29 (2007) 61-68
46. Sharma R., Jarjour W.N., Zheng L., Gaskin F., Fu S.M., and Ju S.T. Large functional repertoire of regulatory T-cell suppressible autoimmune T cells in scurfy mice. J Autoimmun 29 (2007) 10-19
47. van Venrooij W.J., Zendman A.J., and Pruijn G.J. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmun Rev 6 (2006) 37-41
48. Williams Jr. R.C. Autoimmune disease etiology - a perplexing paradox or a turning leaf?. Autoimmun Rev 6 (2007) 204-208
49. Wolin S.L., and Reinisch K.M. The Ro 60 kDa autoantigen comes into focus: interpreting epitope mapping experiments on the basis of structure. Autoimmun Rev 5 (2006) 367-372
50. Abraham M., Karni A., Dembinsky A., Miller A., Gandhi R., Anderson D., et al. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J Autoimmun 30 (2008) 21-28
51. Andreoli L., Pregnolato F., Burlingame R., Allegri F., Rizzini S., Fanelli V., et al. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity. J Autoimmun 30 (2008) 51-57
52. Binard A., Le Pottier L., Saraux A., Devauchelle-Pensec V., Pers J.-O., and Youinou P. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?. J Autoimmun 30 (2008) 63-67
53. Jacobson E., Huber A., and Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30 (2008) 58-62
54. Mackay I., Leskovek N., and Rose N. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 30 (2008) 5-11
55. Nakanishi Y., Tsuneyama K., Fujimoto M., Thucydides L., Nomoto K., An J.-L., et al. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. J Autoimmun 30 (2008) 42-50
56. Poletaev A., Stepanyuk V., and Gershwin M. Integrating immunity: the immunculus and self reactivity. J Autoimmun 30 (2008) 68-73
57. Praprotnik S., Snezna S.-S., Tomsic M., and Shoenfeld Y. The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun 30 (2008) 37-41
58. Recalcati S., Invernizzi P., Arosio P., and Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 30 (2008) 84-89
59. Sanchez-Pernaute O., Ospelt C., Neidhart M., and Gay S. Epigenetic clues to rheumatoid arthritis. J Autoimmun 30 (2008) 12-20
60. Shoenfeld Y., and Gershwin M. Autoimmunity: from the mosaic to the kaleidoscope. J Autoimmun 30 (2008) 1-4